drugset / Trial / NCT04073381

Application of Ergogenic Aids to the Prehabilitation of Abdominal Cancer Patients Undergoing Cancer Surgery

NCT04073381

Phase 0 Completed 92 enrolled University of Texas at Austin
NaSingle-groupOpen-labelPrevention

Summary

The purpose of the proposed study is to measure surgical recovery, including the length of hospital stay, incidence of perioperative complications, and mortality at 90 days post-surgery, in surgical patients with abdominal cancer. The investigators hypothesize that this prehabilitation program will improve recovery and reduce perioperative complications via the proposed prehabilitation intervention.

Timeline

Start
2018-10-28
Primary completion
2020-07-31
Completion
2020-08-31

Drugs

EvaluationDrugModalityDoseRoute
Background Creatine Other / unclassified 8 g
Background L-citrulline Other / unclassified 5 g
Background whey protein Unknown 25 g

Indications

No indication recorded.